News

News
Partner news

Aduro BioTech Secures $55 Million Series C Financing

Read full story
Partner news

CVRx® Achieves Two Significant Milestones for its Heart Failure and Hypertension Businesses

Read full story
Partner news

Rodin Therapeutics Applies Insights of Epigenetics to Neurological Disorders

Read full story
Partner news

Vedanta Enters Collaboration with Johnson & Johnson Innovation Center in Boston

Read full story
Partner news

PhaseBio Expands Clinical Development of Vasomera, an Investigational Treatment for Cardiopulmonary Diseases

Read full story
Partner news

Protagonist Therapeutics Raises $14 Million in Series B Venture Financing

Read full story
Partner news

PhaseBio Initiated Phase 1 Study of Investigational Once-Weekly Basal Insulin for Potential Treatment of Diabetes

Read full story
Partner news

Lonza and BioWa Sign License Agreements with FivePrime Therapeutics for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development

Read full story
Partner news

Astute Medical Completes $40.4 Million Series C Financing

Read full story
Partner news

PhaseBio Pharmaceuticals Received an Additional $23 Million with Completion of the Third Tranche of a Series B Financing for Advancement of Metabolic and Cardiovascular Product Portfolio

Read full story
Partner news

Five Prime Therapeutics Announces that Human Genome Sciences Files U.S. IND for HGS1036/FP-1039 FGF Ligand Trap

Read full story
Partner news

Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results With MYDICAR® Enzyme Replacement Therapy in the Journal Circulation

Read full story
Partner news

Five Prime Therapeutics Provides an Update on its Strategic Discovery Collaborations with Pfizer and GlaxoSmithKline

Read full story
Partner news

Spinal Modulation Secures $30 Million Series D Financing

Read full story
Partner news

Metabolex Enters into Type 2 Diabetes Development and License Agreement

Read full story